PubHawk
Circulation January 2023 PMID 36342475

Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study.

Jeehoon Kang, Kyung Woo Park, Huijin Lee, Doyeon Hwang, Han-Mo Yang, Seung-Woon Rha, Jang-Whan Bae, Nam Ho Lee, Seung-Ho Hur, Jung-Kyu Han, Eun-Seok Shin, Bon-Kwon Koo, Hyo-Soo Kim

Full text PDF Download social card

Mentions

133
Peak: 50 in Aug 2023
across 5 sources since Nov 2022

Extended reach

1,325,226
potential audience

Total likes

454

Video views

647

Mentions per month

Nov 2022 – Aug 2025

Where it's discussed

  • X / Twitter120 posts
  • News6 articles
  • Facebook3 posts
  • YouTube2 videos
  • Blogs2 articles

AI synopsis

What people are saying

The discussions highlight key findings, such as the lower rates of cardiovascular events associated with clopidogrel compared to aspirin, which is reflected in phrases like 'clopidogrel safer and more effective' and 'why do we use aspirin rather than P2Y12 inhibitors for long-term prevention?' The choice of words such as 'better,' 'significant,' and 'reanalysis' showcases a tone of urgency and importance, contributing to the overall sentiment that the study's conclusions are vital for future treatment considerations.

AgreementModerate agreement

Overall, a moderate level of agreement is reflected in the discussions, with many participants supporting or acknowledging the findings of the HOST-EXAM study.

InterestHigh interest

There is a high level of curiosity surrounding the article, as many participants engage with the findings and express interest in the implications for treatment.

EngagementModerate engagement

While many posts engage with the study's results, some responses are dismissive, suggesting varying depths of engagement on the topic.

ImpactHigh impact

The perceived impact of the study is significant, as participants recognize its importance for clinical practice in cardiology.

Abstract in brief

  • The HOSTEXAM Extended Study compared long-term outcomes of clopidogrel versus aspirin in patients who underwent percutaneous coronary intervention with drug-eluting stents.
  • A total of 5,438 patients who were free of clinical events after 12 months of dual antiplatelet therapy were assigned to either clopidogrel 75 mg or aspirin 100 mg daily, with the study focusing on a median follow-up of about 5.8 years.
  • Results show that clopidogrel was associated with lower risks for major cardiovascular events and bleeding complications compared to aspirin, suggesting it may be a more effective option for long-term maintenance therapy.
Read the full abstract

Top posts

Most liked on X and Bluesky
Circulation
@CircAHA · X

#OriginalResearch: Clopidogrel monotherapy was superior to aspirin monotherapy (following 6-18 mo DAPT) in long term follow-up of patients who received coronary stenting #AHAJournals https://t.co/UY7s9MyjPe https://t.co/QgGczLjudn

Jan 17, 2023 · 136 likes · 56 shares · 77,458 followers View post →
C. Michael Gibson MD
@CMichaelGibson · X

The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommendation for chronic CAD thx. Based on the HOST Exam trial https://t.co/HXXn9uxIlb and the CAPRIE trial https://t.co/hGGrZppFLv what is your practice? #esccongress

Aug 25, 2023 · 129 likes · 49 shares · 431,988 followers View post →
ふぁるくま@薬局薬剤師
@farukumayaku · X

「抗血小板薬1剤残すならP2Y12i」は知らなかった

Feb 4, 2023 · 83 likes · 10 shares · 596 followers View post →
SABOURETCardiologist
@SABOURETCardio · X

Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 18, 2023 · 49 likes · 19 shares · 31,187 followers View post →
エビデンスおばさん（健康情報）
@EvidenceObasan · X

poor metabolizer問題はありますが，長期でみるとやはりクロピドグレルは良い薬ですよねえ。 ■PCI後DAPT後，SAPTどっち残すか問題RCT(n=5438)：Clop75 vs ASA100 で心血管イベント(12.8% vs 16.9%)も出血イベント(4.5% vs 6.1%)もClopが優越性。 追跡期間中央値は約6年！ https://t.co/qh9qQQVz03

Jan 29, 2023 · 12 likes · 1 share · 5,550 followers View post →
文献メモ
@bunken_kensaku · X

【文献メモ】(こっちですね！) Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study https://t.co/roxMLm77lW

Mar 13, 2024 · 9 likes · 2 shares · 272 followers View post →

All mentions

Shloime Perel
@Shloim · X

https://t.co/DmVYdone6S

Aug 31, 2025 · 625 followers View post →
Jeffrey Chan, MBChB MPH FESC
@JeffreyChansky · X

@drkeithsiau @drmineg @battyberd Sorry but I recall multiple studies saying that clopidogrel is associated with lower bleeding risk than aspirin? https://t.co/pXue3Isd53 https://t.co/seGQjJPV0v

Dec 31, 2024 · 383 followers View post →
循環器病薬剤師ネットワーク(#循薬ネット)
@Cardio_Pharm_JP · X

RT @bunken_kensaku: 【文献メモ】(こっちですね！) Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Interventi…

Mar 13, 2024 · 2 shares · 4,416 followers View post →
Tororo_ph@EP Univ. oshademic
@tororo__ph · X

RT @bunken_kensaku: 【文献メモ】(こっちですね！) Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Interventi…

Mar 13, 2024 · 2 shares · 6,789 followers View post →
文献メモ
@bunken_kensaku · X

【文献メモ】(こっちですね！) Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study https://t.co/roxMLm77lW

Mar 13, 2024 · 9 likes · 2 shares · 272 followers View post →
Gem Mohan
@drgemmohan · X

@DrRajeshG1 @drmjp93 @DrSanjay277 @Vighrane01 @drmohansai https://t.co/sFr8uis1Oz Actually plavix monotherapy is better, sir. Conclusively proven recently.

Jan 12, 2024 · 83 followers View post →
Hooman Bakhshi
@BakhshiHooman · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 27, 2023 · 49 shares · 6,811 followers View post →
Wissam Gharib
@aitawi1 · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 165 followers View post →
Catherine J. Goodenough
@cathgoodenough · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 687 followers View post →
bujaj49
@bujaj49 · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 1,036 followers View post →
Rodolfo Gaona
@RGcardio · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 633 followers View post →
Dr Agibus
@Dr_Agibus · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 8,947 followers View post →
Dr. Birep Aygün
@genperisi · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 13,712 followers View post →
Jef Van den Eynde
@JefVandenEynde · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 876 followers View post →
regayip zehir
@regayip333 · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 148 followers View post →
Poornima Mohan
@PoornimaMohan10 · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 442 followers View post →
LUIS GARCIA CARRION
@LGARCIALSM · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 484 followers View post →
Francesco Dellagrazia
@_radikalek · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 1,593 followers View post →
Roger Blumenthal
@rblument1 · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 8,852 followers View post →
Dr Ihab Suliman
@IhabFathiSulima · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 88,757 followers View post →
Dr. Michael Sagner, MD
@DrMichaelSagner · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 5,358 followers View post →
Pascal Meier,MD
@DrPascalMeier · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 111,291 followers View post →
Linda
@wordfinga · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 4,589 followers View post →
Sahar Memar Montazerin, MD
@MmrSahar · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 1,294 followers View post →
Daniel
@ikeror112 · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 57 followers View post →
Suzanna
@SuzannadeVries · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 387 followers View post →
vinaymalhotra
@vmalhotra2013 · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 65 followers View post →
Karl Dujardin
@KDujardin · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 645 followers View post →
Garcia Pinilla
@marlucale37 · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 1,138 followers View post →
Mamas A. Mamas
@mmamas1973 · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 79,940 followers View post →
Alex Kharlamov MD FESC FACC FEACVI
@drskharlamov · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 1,678 followers View post →
Tenich
@Marktenich · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 341 followers View post →
Dr.SGanta@PharmD
@SaiduluGanta · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 764 followers View post →
Tomohiro Fujisaki
@TomohiroFujisa2 · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 26, 2023 · 49 shares · 652 followers View post →
Kananura Keneth
@kkananura · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 4,240 followers View post →
Ganesan
@ganesh48205798 · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 36 followers View post →
Dr. Michael Alexander
@MichaelAlexandp · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 853 followers View post →
Umut Kocabaş
@UmutKocabasMD · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 1,470 followers View post →
Bryana Tysick
@BryanaTysick · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 61 followers View post →
Natsir Ramadhan
@natsiradhan · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 564 followers View post →
Reuben Elovitz MD
@Concierge__MD · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 247 followers View post →
Mounir Basalus (Ⲃⲁⲥⲓⲗⲓⲟⲥ)
@Basalus · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 4,964 followers View post →
John P Erwin III MD MBA MACC (#BigPoppy )
@HeartOTXHeartMD · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 39,674 followers View post →
Ирина Баринова
@DAZy81 · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 35 followers View post →
dachuang wei
@Dr_littleheart · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 30 followers View post →
Dr Dolce
@ValdoCasMtz · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 1,446 followers View post →
Dr. Sou
@SwissHeartDoc · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 881 followers View post →
rafavidalperez
@rafavidalperez · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 13,844 followers View post →
Dr. Martha Gulati ♥️
@DrMarthaGulati · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 64,839 followers View post →
Bala Tangiisuran
@DrTangiisuran · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 289 followers View post →
European Society of Cardiology
@escardio · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 149,660 followers View post →
Ovidio García
@ovidiogarciav · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 3,531 followers View post →
TARIQ RASHID MD DM
@drtariqcardio · X

RT @CMichaelGibson: The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommend…

Aug 25, 2023 · 49 shares · 68 followers View post →
C. Michael Gibson MD
@CMichaelGibson · X

The new ESC guidelines give Aspirin mono therapy a Class 1 recommendation & thienopyridine therapy a class 2b recommendation for chronic CAD thx. Based on the HOST Exam trial https://t.co/HXXn9uxIlb and the CAPRIE trial https://t.co/hGGrZppFLv what is your practice? #esccongress

Aug 25, 2023 · 129 likes · 49 shares · 431,988 followers View post →
色々自粛中(ガラス細工の様な繊細なハートを持つ貴公子
@ECGEPSCADEVICE · X

RT @Cardio_Pharm_JP: https://t.co/8oclj77pTN

Aug 17, 2023 · 2 shares · 9,378 followers View post →
循環器病薬剤師ネットワーク(#循薬ネット)
@Cardio_Pharm_JP · X

https://t.co/8oclj77pTN

Aug 17, 2023 · 3 likes · 2 shares · 4,416 followers View post →
Scotty Kirkpatrick M.D.
@drscottyk · X

During a median follow-up of 5.8 years in those 6-18 months after PCI, clopidogrel had lower rates of both the secondary thrombotic and secondary bleeding endpoints compared to aspirin with combined NNT of 37. https://t.co/LwFnpbbRzO

Apr 20, 2023 · 4 likes · 2,789 followers View post →
Bernardo Vidal Pimentel
@BVidalPimentel · X

SAPT: Aspirin or clopidogrel? HOST-EXAM trial (Lancet 21): Clopidogrel safer and more effective » Reanalysis at 6y w/ maintained benefit I haven't seen it into practice. Status quo? South-coreans only? If 2nd, not the only study but maybe best so far https://t.co/ykaOuQGzce

Apr 19, 2023 · 288 followers View post →
いっち21#積雪カウントダウン
@LTto21 · X

RT @farukumayaku: 「抗血小板薬1剤残すならP2Y12i」は知らなかった

Feb 6, 2023 · 10 shares · 659 followers View post →
TT /精神科備忘録
@EgBopt37gajSY4H · X

RT @farukumayaku: 「抗血小板薬1剤残すならP2Y12i」は知らなかった

Feb 5, 2023 · 10 shares · 201 followers View post →
hataboSAN
@hataboSAN · X

RT @farukumayaku: 「抗血小板薬1剤残すならP2Y12i」は知らなかった

Feb 5, 2023 · 10 shares · 1,009 followers View post →
Satoru Mitsuboshi
@3stars67664378 · X

RT @farukumayaku: 「抗血小板薬1剤残すならP2Y12i」は知らなかった

Feb 5, 2023 · 10 shares · 1,786 followers View post →
クワッス
@priparadaisuki1 · X

RT @farukumayaku: 「抗血小板薬1剤残すならP2Y12i」は知らなかった

Feb 5, 2023 · 10 shares · 142 followers View post →
エアランゲン(Erlangen)
@lachensmile · X

RT @farukumayaku: 「抗血小板薬1剤残すならP2Y12i」は知らなかった

Feb 5, 2023 · 10 shares · 369 followers View post →
たけちゃん
@nitrotake · X

RT @farukumayaku: 「抗血小板薬1剤残すならP2Y12i」は知らなかった

Feb 5, 2023 · 10 shares · 1,441 followers View post →
はぎ
@hagi220 · X

RT @farukumayaku: 「抗血小板薬1剤残すならP2Y12i」は知らなかった

Feb 5, 2023 · 10 shares · 492 followers View post →
Hiroyuki Sato 佐藤宏行
@foreverhero0819 · X

RT @farukumayaku: 「抗血小板薬1剤残すならP2Y12i」は知らなかった

Feb 5, 2023 · 10 shares · 3,822 followers View post →
ふぁるくま@薬局薬剤師
@farukumayaku · X

「抗血小板薬1剤残すならP2Y12i」は知らなかった

Feb 4, 2023 · 83 likes · 10 shares · 596 followers View post →
C☻Chihiro
@oki_13_love · X

RT @EvidenceObasan: poor metabolizer問題はありますが，長期でみるとやはりクロピドグレルは良い薬ですよねえ。 ■PCI後DAPT後，SAPTどっち残すか問題RCT(n=5438)：Clop75 vs ASA100 で心血管イベント(12.8%…

Jan 29, 2023 · 1 share · 53 followers View post →
エビデンスおばさん（健康情報）
@EvidenceObasan · X

poor metabolizer問題はありますが，長期でみるとやはりクロピドグレルは良い薬ですよねえ。 ■PCI後DAPT後，SAPTどっち残すか問題RCT(n=5438)：Clop75 vs ASA100 で心血管イベント(12.8% vs 16.9%)も出血イベント(4.5% vs 6.1%)もClopが優越性。 追跡期間中央値は約6年！ https://t.co/qh9qQQVz03

Jan 29, 2023 · 12 likes · 1 share · 5,550 followers View post →
Iñaki Sánchez Amezua
@jisaname · X

RT @rincondesisifo: (Circulation) Seguridad y eficacia a largo plazo del ácido acetilsalicílico vs clopidogrel en monoterapia en pac que ha…

Jan 28, 2023 · 2 shares · 1,104 followers View post →
Joaquin Cedeño
@JoaquinCedeo2 · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 28, 2023 · 19 shares · 149 followers View post →
SABOURETCardiologist
@SABOURETCardio · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 28, 2023 · 19 shares · 31,187 followers View post →
Antonio Manteca
@amango30 · X

RT @RevistaMFSamfyc: Aspirina frente a clopidogrel para terapia de mantenimiento a largo plazo tras intervención coronaria percutánea: estu…

Jan 28, 2023 · 1 share · 138 followers View post →
Revista MFAndalucia
@RevistaMFSamfyc · X

Aspirina frente a clopidogrel para terapia de mantenimiento a largo plazo tras intervención coronaria percutánea: estudio HOST-EXAM extendido https://t.co/BIbgeFq1Bd PMID 36342475

Jan 24, 2023 · 1 like · 1 share · 723 followers View post →
Heather L Gornik
@heatherlgornik · X

RT @SABOURETCardio: Do you still use #Aspirin Instead of #Clopidogrel for Long-Term Maintenance Monotherapy After #PCI ? Just consider the…

Jan 21, 2023 · 16 shares · 4,346 followers View post →
Luiz André Almeida
@luizandr7 · X

RT @SABOURETCardio: Do you still use #Aspirin Instead of #Clopidogrel for Long-Term Maintenance Monotherapy After #PCI ? Just consider the…

Jan 21, 2023 · 16 shares · 201 followers View post →
SABOURETCardiologist
@SABOURETCardio · X

RT @SABOURETCardio: Do you still use #Aspirin Instead of #Clopidogrel for Long-Term Maintenance Monotherapy After #PCI ? Just consider the…

Jan 21, 2023 · 16 shares · 31,187 followers View post →
Ross Buhay
@RossLife88 · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 19, 2023 · 19 shares · 15 followers View post →
rafaelportalupp
@rafaelportalup2 · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 19, 2023 · 19 shares · 457 followers View post →
Tatev Grigoryan
@Ta_Thev · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 19, 2023 · 19 shares · 42 followers View post →
ong beng hooi
@ongbenghooi1 · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 19, 2023 · 19 shares · 545 followers View post →
Dr. Hitesh Rajpurohit
@HITUGALBANI · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 19, 2023 · 19 shares · 643 followers View post →
Trung Nguyen
@drtrungnguyen · X

RT @ChaturvediNeuro: HOST-EXAM extension study in @CircAHA shows 26% decrease in major adverse events (thrombotic events, major bleed) 12…

Jan 19, 2023 · 3 shares · 1,392 followers View post →
Edson Makambwa
@EdsonMakambwa · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 19, 2023 · 19 shares · 41 followers View post →
Malik Ghannam
@GhannamMalik · X

RT @ChaturvediNeuro: HOST-EXAM extension study in @CircAHA shows 26% decrease in major adverse events (thrombotic events, major bleed) 12…

Jan 18, 2023 · 3 shares · 837 followers View post →
Ferald
@feraldlaksh1 · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 18, 2023 · 19 shares · 20 followers View post →
Juan Fer Carvajal
@juan_carvaj · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 18, 2023 · 19 shares · 195 followers View post →
Greg Perry
@ID_GregPerry · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 18, 2023 · 19 shares · 256 followers View post →
Kristy Xinghan Fu
@FuXinghan · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 18, 2023 · 19 shares · 460 followers View post →
Ganesan
@ganesh48205798 · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 18, 2023 · 19 shares · 36 followers View post →
Smit Patel, MD, MPH
@SmitdPat · X

RT @ChaturvediNeuro: HOST-EXAM extension study in @CircAHA shows 26% decrease in major adverse events (thrombotic events, major bleed) 12…

Jan 18, 2023 · 3 shares · 248 followers View post →
Dr Jainer Mendez
@JainerDr · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 18, 2023 · 19 shares · 318 followers View post →
Wissam Gharib
@aitawi1 · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 18, 2023 · 19 shares · 165 followers View post →
Seemant Chaturvedi
@ChaturvediNeuro · X

HOST-EXAM extension study in @CircAHA shows 26% decrease in major adverse events (thrombotic events, major bleed) 12 mos after PCI with clopidogrel mono-rx vs. aspirin. Should stroke clinicians convert more pts to clop. mono-rx after a course of DAPT? https://t.co/OMIAQqQ0xR

Jan 18, 2023 · 6 likes · 3 shares · 3,332 followers View post →
DiabetoPitie
@DiabetoPitie · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 18, 2023 · 19 shares · 290 followers View post →
Erik Rafflenbeul
@KardiologieHH · X

RT @SABOURETCardio: Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 18, 2023 · 19 shares · 8,712 followers View post →
SABOURETCardiologist
@SABOURETCardio · X

Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy #PCI #SAPT https://t.co/XuQy6gLOls

Jan 18, 2023 · 49 likes · 19 shares · 31,187 followers View post →
Amitabh C. Pandey
@AmitabhCPandey · X

Why do we used aspirin rather than p2y12 inhibitors for longterm secondary prevention after #PCI. 5438 patients randomized 1:1 after a yr of #DAPT clopidogrel vs asa. clopidogrel w/⬇️net outcomes. Is it time to switch? Read more

Jan 18, 2023 · 1 like · 517 followers View post →
Leopoldo S Piegas
@LPiegas · X

Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study | Circulation https://t.co/c6o446QW96

Jan 17, 2023 · 2 likes · 168 followers View post →
Juan Felipe
@Juanfebeme · X

RT @CircAHA: #OriginalResearch: Clopidogrel monotherapy was superior to aspirin monotherapy (following 6-18 mo DAPT) in long term follow-up…

Jan 17, 2023 · 56 shares · 25 followers View post →
Francisco L. Zapata
@flzapatac · X

RT @CircAHA: #OriginalResearch: Clopidogrel monotherapy was superior to aspirin monotherapy (following 6-18 mo DAPT) in long term follow-up…

Jan 17, 2023 · 56 shares · 149 followers View post →
Chris
@AdtebeateIoseph · X

RT @CircAHA: #OriginalResearch: Clopidogrel monotherapy was superior to aspirin monotherapy (following 6-18 mo DAPT) in long term follow-up…

Jan 17, 2023 · 56 shares · 337 followers View post →
Nicolás Núñez
@Nicolas_Nunez32 · X

RT @CircAHA: #OriginalResearch: Clopidogrel monotherapy was superior to aspirin monotherapy (following 6-18 mo DAPT) in long term follow-up…

Jan 17, 2023 · 56 shares · 21 followers View post →
Andi Rroku
@rroku_andi · X

RT @CircAHA: #OriginalResearch: Clopidogrel monotherapy was superior to aspirin monotherapy (following 6-18 mo DAPT) in long term follow-up…

Jan 17, 2023 · 56 shares · 395 followers View post →
Tom Levin, MD
@tlevin · X

RT @SABOURETCardio: Do you still use #Aspirin Instead of #Clopidogrel for Long-Term Maintenance Monotherapy After #PCI ? Just consider the…

Jan 17, 2023 · 16 shares · 306 followers View post →
Leonardo De Luca, MD, PhD, FACC, FESC
@leonardodeluca · X

RT @CircAHA: #OriginalResearch: Clopidogrel monotherapy was superior to aspirin monotherapy (following 6-18 mo DAPT) in long term follow-up…

Jan 17, 2023 · 56 shares · 194 followers View post →
Yawer Saeed
@SaeedYawer · X

RT @CircAHA: #OriginalResearch: Clopidogrel monotherapy was superior to aspirin monotherapy (following 6-18 mo DAPT) in long term follow-up…

Jan 17, 2023 · 56 shares · 559 followers View post →
Sinisa T Zivkovic
@dragonpn07 · X

RT @CircAHA: #OriginalResearch: Clopidogrel monotherapy was superior to aspirin monotherapy (following 6-18 mo DAPT) in long term follow-up…

Jan 17, 2023 · 56 shares · 342 followers View post →
Circulation
@CircAHA · X

#OriginalResearch: Clopidogrel monotherapy was superior to aspirin monotherapy (following 6-18 mo DAPT) in long term follow-up of patients who received coronary stenting #AHAJournals https://t.co/UY7s9MyjPe https://t.co/QgGczLjudn

Jan 17, 2023 · 136 likes · 56 shares · 77,458 followers View post →
Ivan Stankovic
@Ivan_Echocardio · X

RT @SABOURETCardio: Do you still use #Aspirin Instead of #Clopidogrel for Long-Term Maintenance Monotherapy After #PCI ? Just consider the…

Jan 17, 2023 · 16 shares · 6,124 followers View post →
Christian Backhouse
@cbackq · X

RT @SABOURETCardio: Do you still use #Aspirin Instead of #Clopidogrel for Long-Term Maintenance Monotherapy After #PCI ? Just consider the…

Jan 17, 2023 · 16 shares · 75 followers View post →
Kuniaki Takahashi
@kuniaki_0125 · X

RT @SABOURETCardio: Do you still use #Aspirin Instead of #Clopidogrel for Long-Term Maintenance Monotherapy After #PCI ? Just consider the…

Jan 17, 2023 · 16 shares · 150 followers View post →
Coronary 4Front
@Coronary4front · X

RT @SABOURETCardio: Do you still use #Aspirin Instead of #Clopidogrel for Long-Term Maintenance Monotherapy After #PCI ? Just consider the…

Jan 17, 2023 · 16 shares · 1,785 followers View post →
Natsu_85
@NMtjj85 · X

RT @SABOURETCardio: Do you still use #Aspirin Instead of #Clopidogrel for Long-Term Maintenance Monotherapy After #PCI ? Just consider the…

Jan 17, 2023 · 16 shares · 40 followers View post →
Erwin Téllez MD-Interventional Cardiologist
@erwintellez · X

Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study https://t.co/sbzOuSPx8n #Cardiotwitter

Jan 16, 2023 · 496 followers View post →
Alfredo E Rodriguez
@AlfredoERodrig2 · X

The HOST-EXAM clopidogrel and AAS at 5.8 years similar all cause of death.https://t.co/7qoWjJnHPW If prolonged DAPT isn't the cause of an excess of non-cardiac death in recent DES trials who was? It is hard to believe thats happening by chance, 9903 pts randomized in 4 trials

Nov 28, 2022 · 2 likes · 292 followers View post →
Satoru Mitsuboshi
@3stars67664378 · X

RT @pinacol: 【追跡調査: HOST-EXAM】PCI後のDAPTで臨床イベントがなかった患者へのクロピドグレル投与は、アスピリン投与と比較して、延長した追跡期間中の全原因死亡、非致死性心筋梗塞、脳卒中、急性冠症候群による再入院、BARCタイプ3以上の出血の複合転帰…

Nov 12, 2022 · 2 shares · 1,786 followers View post →
pinacol
@pinacol · X

【追跡調査: HOST-EXAM】PCI後のDAPTで臨床イベントがなかった患者へのクロピドグレル投与は、アスピリン投与と比較して、延長した追跡期間中の全原因死亡、非致死性心筋梗塞、脳卒中、急性冠症候群による再入院、BARCタイプ3以上の出血の複合転帰リスクを減少させた。 #ペ読 https://t.co/I7vrGC1dzo

Nov 12, 2022 · 3 likes · 2 shares · 1,617 followers View post →
Seoul National University Hospital
@snuh_official · X

Clopidogrel monotherapy as compared with aspirin monotherapy was associated with lower rates of the composite net clinical outcome in patients without clinical events for 12±6 months after percutaneous coronary intervention with drug-eluting stents. https://t.co/ddKwhdEOXQ

Nov 9, 2022 · 949 followers View post →